新型PREVENT评分在提示类风湿关节炎亚临床动脉粥样硬化中的表现
类风湿关节炎(RA)患者动脉粥样硬化性心血管疾病(ASCVD)风险升高,但传统10年心血管风险计算工具如2013年汇总队列方程(PCE)在RA中表现不佳。本研究比较PCE与更新版PREVENT算法在提示RA患者亚临床冠状动脉和颈动脉粥样硬化方面的表现。结果显示PREVENT评分并不优于PCE,PCE在RA中已表现不佳,PREVENT算法不太可能充分预测该人群的心血管事件风险。
要点
- PCE评分与各PREVENT评分均显著不同(P < 0.001)。
- 预测CAC >0时,PREVENT ASCVD评分AUROC为0.723,低于PCE的0.775(P = 0.034)。
- 颈动脉斑块方面,PCE与各PREVENT评分AUROC无差异。
核心结论
- 新更新版PREVENT评分在提示RA亚临床冠状动脉和颈动脉粥样硬化方面并不优于之前的PCE。
- 由于PCE评分在RA患者中已表现不佳,PREVENT算法不太可能充分预测该人群的心血管疾病事件风险。
研究设计与样本
- 纳入无已知心血管疾病的RA患者,行胸部CT量化冠状动脉钙化(CAC)评分,行颈动脉超声确定颈动脉斑块存在与否。
- 计算PCE评分及三种10年PREVENT评分:Total CVD、ASCVD和Total CVD联合尿白蛋白-肌酐比值(uACR),并比较各评分提示CAC和颈动脉斑块的表现。
主要发现
- PCE评分与各PREVENT评分均显著不同(P < 0.001)。
- PCE与PREVENT评分均与所有水平的CAC及颈动脉斑块显著相关。
- 预测CAC >0时,PREVENT ASCVD评分AUROC为0.723,低于PCE的AUROC 0.775(P = 0.034)。
- 对于颈动脉斑块,PCE与PREVENT ASCVD、PREVENT Total CVD或PREVENT Total CVD + uACR评分的AUROC之间无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Patients with rheumatoid arthritis (RA) are at increased risk of atherosclerotic cardiovascular disease (ASCVD), yet traditional 10-year CVD risk calculators - such as the 2013 Pooled Cohort Equations (PCE) - underperform in RA. Our objective was to determine the performance of the PCE vs the updated PREVENT algorithm in indicating presence of subclinical coronary and carotid atherosclerosis in RA. METHODS: Patients with RA without known CVD underwent chest CT to quantify a coronary artery calcium (CAC) score and carotid artery ultrasound to determine presence of carotid artery plaque. The PCE score and three 10-year PREVENT scores - Total CVD, ASCVD and Total CVD with urine albumin-to-creatinine ratio (uACR) - were calculated; scores were compared in their performance to indicate CAC and presence of carotid plaque. RESULTS: The PCE score was significantly different from each of the PREVENT scores (P < 0.001). The PCE and the PREVENT scores were significantly associated with all levels of CAC and carotid plaque. In predicting CAC >0, the PREVENT ASCVD score area under the receiver operating characteristic curve (AUROC) was 0.723, lower than the PCE AUROC of 0.775 (P = 0.034). For carotid plaque, there was no difference in AUROC between the PCE and the PREVENT ASCVD, PREVENT Total CVD score or PREVENT Total CVD + uACR score. CONCLUSION: The newly updated PREVENT scores are not better than the prior PCE for indicating subclinical coronary and carotid atherosclerosis in RA. Because the PCE score already underperforms in RA patients, it is unlikely that the PREVENT algorithm will adequately predict CVD event risk in this population.
引用
- Gibbons JAB, Bathon JM, Giles JT, et al. Performance of the new PREVENT score for indicating subclinical atherosclerosis in rheumatoid arthritis. Rheumatology (Oxford). 2025. PMID: 40411757. doi:10.1093/rheumatology/keaf267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。